Related Experiment Video
Updated: Sep 22, 2025

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
Retinal Ganglion Cell Death in Glaucoma: Advances and Caveats
Yuting Yang1, Xinghuai Sun1,2,3
1Department of Ophthalmology & Visual Science, Eye & ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Abstract:
Purpose: Retinal ganglion cell death occurs during the glaucoma pathological process, and it is significant because of the poor regeneration capacity of retinal ganglion cells. With a constantly increasing understanding of retinal cell death mechanisms, we now know that simply blocking a specific mechanism of cell death might not prevent retinal ganglion cell death. This review aimed to summarize the mechanisms of retinal cell death in glaucoma models and discuss the caveats in restoring visual function in these studies.Methods: A literature search was done on PubMed using key words including glaucoma, ocular hypertension, retinal ganglion cell, cell death, apoptosis, necroptosis, pyroptosis, ferroptosis, autophagic cell death, and parthanatos. The literature was reviewed to summarize the information about the lethal pathways of retinal ganglion cell in the glaucoma-like animal models.Results: Based on the purpose, 100 studies were selected and discussed in this review.Conclusions: The damage to ganglion cells in glaucoma-like animals can occur via multiple lethal pathways and the molecular mechanisms are still incompletely understood. Further investigations on the crosstalk between different cell death pathways and the common upstream regulators could augment the development of novel targeting agents for the curative treatment of glaucoma.
Insights
Glaucoma causes retinal ganglion cell death through multiple pathways, not just one. Understanding these complex cell death mechanisms is key to developing effective treatments for vision loss.
Area of Science:
- Ophthalmology
- Neuroscience
- Cell Biology
Background:
- Retinal ganglion cell (RGC) death is a hallmark of glaucoma, leading to irreversible vision loss due to RGCs' limited regenerative capacity.
- Current understanding suggests that targeting a single cell death pathway may be insufficient to prevent RGC loss in glaucoma.
Conclusions:
- RGC death in glaucoma is a multifactorial process.
- Further research into the crosstalk between different cell death pathways and shared upstream regulators is crucial.
- This knowledge can guide the development of novel therapeutic agents for glaucoma treatment.
More Related Videos
09:46An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina
Published on: July 15, 2025
13:12Partial Optic Nerve Transection in Rats: A Model Established with a New Operative Approach to Assess Secondary Degeneration of Retinal Ganglion Cells
Published on: October 15, 2017
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Anatomy of the Eyeball